bioRxivCancer BiologyPreprint
Cellular Composition Accounts for Much of the Bulk Glutamine-IFN-γ Transcriptional Axis in Melanoma: A Cross-Cohort and Single-Cell Analysis
Abstract
BackgroundAn inverse relationship between glutamine-associated and interferon-{gamma} (IFN-{gamma})-associated transcription in bulk melanoma could indicate metabolic antagonism or simply different cellular origins. We tested these alternatives and evaluated prognostic and immunotherapy-response associations. MethodsContinuous GSVA scores were analyzed in TCGA-SKCM (469 tumors), an independent melanoma survival cohort (GSE65904; 214 tumors), a pretreatment nivolumab cohort (GSE91061; 49 tumors), and single-cell RNA sequencing from 19 patients (GSE72056; 4,645 cells). Cox models used harmonized endpoints and clinical covariates. Bulk composition was examined with ABSOLUTE purity, EPIC, and MCP-counter. Single-cell scores were summarized by patient and compartment; paired tests treated patients, not cells, as independent units. Response models used Firth logistic regression, leave-one-out discrimination, and simulation-based precision analysis. ResultsIn TCGA, the candidate scores were inversely correlated before adjustment (r=-0.397; 95% CI -0.470 to -0.318) but progressively attenuated after purity/sample-type adjustment (r=-0.218), EPIC adjustment (r=-0.146), and MCP-counter adjustment (r=0.019). Single-cell analysis localized higher glutamine-associated scores to malignant cells than paired T, NK, or B-cell compartments, while IFN-{gamma}-associated scores were lower in malignant cells than paired T-cell and macrophage compartments. IFN-{gamma} was associated with lower mortality in TCGA (adjusted hazard ratio [HR] per SD 0.648; 95% CI 0.555-0.757) and GSE65904 (HR 0.667; 95% CI 0.534-0.835). Glutamine-associated scores were not independently prognostic in TCGA (HR 0.966; p=0.673) and were uncertain in GSE65904 (HR 0.823; p=0.084). The interaction was null in TCGA, nominal for the candidate sets in GSE65904, and null with curated sets. No response association was supported in GSE91061; approximately an odds ratio of 3.25 per SD was required for 80% simulated power. ConclusionsCellular composition accounts for much of the bulk glutamine-IFN-{gamma} transcriptional axis in melanoma. IFN-{gamma}-associated transcription is a reproducible prognostic correlate, but glutamine-associated transcription provides no stable incremental outcome information. These data do not establish metabolic competition or treatment prediction; spatial or functional measurements and larger treatment-comparative cohorts are needed.
- organism: human
- assay: bulk RNA-seq
- assay: scRNA-seq
- research focus: protein folding & dynamics
- approach: statistical model
- approach: machine learning (classical)
- Citations
- 0
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Glycolysis and interferon transcription in melanoma immunotherapy
- Single Cell RNA Sequencing Analysis of Human Melanoma Reveals A Distinct Prognostic Myeloid Cell
M. Usman Ahmad, Lyong Heo, … Amanda Kirane·bioRxiv·Mar 5, 2025
- Adverse prognosis of GM-CSF expression in human cutaneous melanoma
Elena García‐Martínez, Alicia Nieto‐Valle, … Rafael Samaniego·NeoplasiaPeer-reviewed·Oct 18, 2025
- G-CSF associates with poor survival in cutaneous melanoma and promotes metastasis through coordinated effects on macrophages and tumor cells
Alicia Nieto‐Valle, Lucía Barandalla-Revilla, … Rafael Samaniego·bioRxiv·Jun 4, 2026
- Glutamine and GLS1 are key metabolic checkpoints that Limit T cell Infiltration and Function in HNSCC
Sonja Decking, Ines Ugele, … Kathrin Renner·bioRxiv·Sep 28, 2026
- A TCF4/BRD4-dependent regulatory network confers cross-resistance to targeted and immune checkpoint therapy in melanoma
J. Pozniak, D. Pedri, … J.-C. Marine·bioRxiv·Aug 11, 2022